Suffolk, United Kingdom

Nicholas Leslie Meyers

This inventor holds 1 USPTO granted patent. Top assignee: Alizyme Therapeutics Limited. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas Leslie Meyers. Retrieved from https://idiyas.com/inventor/nicholas-leslie-meyers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nicholas Leslie Meyers

Introduction

Nicholas Leslie Meyers is a notable inventor based in Suffolk, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of complex compounds. His work has led to the development of innovative processes that enhance the production of valuable chemical substances.

Latest Patents

Nicholas holds a patent for an improved process for the production of [(±)-endo]-4-amino-5-chloro-2-methoxy-N-(1-azabicyclo[3.3.1]non-4-yl)benzamide hydrochloride. This invention not only showcases his expertise but also highlights his commitment to advancing pharmaceutical chemistry.

Career Highlights

Nicholas is currently associated with Alizyme Therapeutics Limited, where he applies his knowledge and skills to further the company's research and development efforts. His work at Alizyme Therapeutics has positioned him as a key player in the field of therapeutic innovations.

Collaborations

Throughout his career, Nicholas has collaborated with esteemed colleagues, including Richard Michael John Palmer and John Knight. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Nicholas Leslie Meyers is a distinguished inventor whose contributions to pharmaceutical synthesis are noteworthy. His innovative processes and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…